Bionano Genomics, Inc. Quarterly Debt-to-equity in % from Q2 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bionano Genomics, Inc. quarterly Debt-to-equity history and growth rate from Q2 2019 to Q2 2024.
  • Bionano Genomics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 80.7 %, a 263% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 80.7 +58.5 +263% Jun 30, 2024
Q1 2024 61.1 +42.2 +224% Mar 31, 2024
Q4 2023 45.1 +29.7 +192% Dec 31, 2023
Q3 2023 29.3 +16.4 +128% Sep 30, 2023
Q2 2023 22.2 +11.9 +115% Jun 30, 2023
Q1 2023 18.9 +10.9 +138% Mar 31, 2023
Q4 2022 15.4 +8.86 +135% Dec 31, 2022
Q3 2022 12.8 +5.77 +81.8% Sep 30, 2022
Q2 2022 10.4 -0.88 -7.84% Jun 30, 2022
Q1 2022 7.94 -14.9 -65.2% Mar 31, 2022
Q4 2021 6.57 -182 -96.5% Dec 31, 2021
Q3 2021 7.05 -485 -98.6% Sep 30, 2021
Q2 2021 11.2 +4.58K Jun 30, 2021
Q1 2021 22.9 +1.13K Mar 31, 2021
Q4 2020 188 -13.4K -98.6% Dec 31, 2020
Q3 2020 492 -764 -60.8% Sep 30, 2020
Q2 2020 -4.57K -4.84K -1800% Jun 30, 2020
Q1 2020 -1.11K Mar 31, 2020
Q4 2019 13.6K Dec 31, 2019
Q3 2019 1.26K Sep 30, 2019
Q2 2019 269 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.